Back to Search Start Over

Expert Perspectives on COVID-19 Vaccination for People Living with Multiple Sclerosis

Authors :
Kottil Rammohan
Mitzi J. Williams
Robert K. Shin
Source :
Neurology and Therapy
Publication Year :
2021
Publisher :
Springer Science and Business Media LLC, 2021.

Abstract

Graphical Plain Language Summary COVID-19 vaccines are safe for people living with MS on or off disease-modifying therapies and are important for the prevention of COVID-19. Antibody responses for individuals on certain DMTs may be diminished, however, T-cell responses may be preserved in those individuals. Data are lacking regarding optimal timing of vaccinations, and delaying disease-modifying therapies may increase the risk of disease activity and progression. In this perspective podcast, the authors recommend COVID-19 vaccination as soon as possible, regardless of timing considerations, in most cases. Electronic supplementary material The online version of this article (10.1007/s40120-021-00266-z) contains supplementary material, which is available to authorized users.

Details

ISSN :
21936536 and 21938253
Volume :
10
Database :
OpenAIRE
Journal :
Neurology and Therapy
Accession number :
edsair.doi.dedup.....8043de885b6b3c449e4a770ec83dc101
Full Text :
https://doi.org/10.1007/s40120-021-00266-z